nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—chronic obstructive pulmonary disease	0.246	0.41	CbGaD
Minocycline—ALOX5—Montelukast—chronic obstructive pulmonary disease	0.219	1	CbGbCtD
Minocycline—VEGFA—chronic obstructive pulmonary disease	0.18	0.3	CbGaD
Minocycline—MMP9—chronic obstructive pulmonary disease	0.174	0.29	CbGaD
Minocycline—CASP3—alveolus of lung—chronic obstructive pulmonary disease	0.0191	0.266	CbGeAlD
Minocycline—IL1B—leg—chronic obstructive pulmonary disease	0.0062	0.0864	CbGeAlD
Minocycline—CASP1—respiratory system—chronic obstructive pulmonary disease	0.00234	0.0326	CbGeAlD
Minocycline—CYCS—respiratory system—chronic obstructive pulmonary disease	0.00225	0.0314	CbGeAlD
Minocycline—CASP1—connective tissue—chronic obstructive pulmonary disease	0.00206	0.0287	CbGeAlD
Minocycline—CYCS—connective tissue—chronic obstructive pulmonary disease	0.00198	0.0276	CbGeAlD
Minocycline—CASP3—respiratory system—chronic obstructive pulmonary disease	0.00193	0.0269	CbGeAlD
Minocycline—CASP1—bronchus—chronic obstructive pulmonary disease	0.00192	0.0268	CbGeAlD
Minocycline—CYCS—bronchus—chronic obstructive pulmonary disease	0.00185	0.0258	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00181	0.0252	CbGeAlD
Minocycline—CASP1—trachea—chronic obstructive pulmonary disease	0.00173	0.0241	CbGeAlD
Minocycline—CASP3—connective tissue—chronic obstructive pulmonary disease	0.0017	0.0236	CbGeAlD
Minocycline—Doxycycline—MMP1—chronic obstructive pulmonary disease	0.0016	0.663	CrCbGaD
Minocycline—CASP3—bronchus—chronic obstructive pulmonary disease	0.00159	0.0221	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00155	0.0216	CbGeAlD
Minocycline—IL1B—respiratory system—chronic obstructive pulmonary disease	0.00154	0.0215	CbGeAlD
Minocycline—CASP3—trachea—chronic obstructive pulmonary disease	0.00142	0.0198	CbGeAlD
Minocycline—IL1B—connective tissue—chronic obstructive pulmonary disease	0.00136	0.0189	CbGeAlD
Minocycline—MMP9—respiratory system—chronic obstructive pulmonary disease	0.00128	0.0179	CbGeAlD
Minocycline—IL1B—bronchus—chronic obstructive pulmonary disease	0.00127	0.0177	CbGeAlD
Minocycline—VEGFA—bronchus—chronic obstructive pulmonary disease	0.00125	0.0174	CbGeAlD
Minocycline—CASP1—lung—chronic obstructive pulmonary disease	0.00124	0.0173	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00124	0.0173	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—chronic obstructive pulmonary disease	0.00122	0.017	CbGeAlD
Minocycline—CYCS—lung—chronic obstructive pulmonary disease	0.00119	0.0166	CbGeAlD
Minocycline—MMP9—connective tissue—chronic obstructive pulmonary disease	0.00113	0.0157	CbGeAlD
Minocycline—VEGFA—trachea—chronic obstructive pulmonary disease	0.00112	0.0156	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—chronic obstructive pulmonary disease	0.00103	0.0144	CbGeAlD
Minocycline—CASP3—lung—chronic obstructive pulmonary disease	0.00102	0.0143	CbGeAlD
Minocycline—ALOX5—respiratory system—chronic obstructive pulmonary disease	0.00101	0.0141	CbGeAlD
Minocycline—ALOX5—connective tissue—chronic obstructive pulmonary disease	0.000893	0.0124	CbGeAlD
Minocycline—ALOX5—bronchus—chronic obstructive pulmonary disease	0.000835	0.0116	CbGeAlD
Minocycline—IL1B—lung—chronic obstructive pulmonary disease	0.000818	0.0114	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—chronic obstructive pulmonary disease	0.000817	0.0114	CbGeAlD
Minocycline—VEGFA—lung—chronic obstructive pulmonary disease	0.000804	0.0112	CbGeAlD
Minocycline—MMP9—lung—chronic obstructive pulmonary disease	0.000681	0.00949	CbGeAlD
Minocycline—Methacycline—ALB—chronic obstructive pulmonary disease	0.000566	0.234	CrCbGaD
Minocycline—ALOX5—lung—chronic obstructive pulmonary disease	0.000539	0.00751	CbGeAlD
Minocycline—IL1B—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.000524	0.18	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.000512	0.176	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.000325	0.112	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.109	CbGdCrCtD
Minocycline—Tetracycline—ALB—chronic obstructive pulmonary disease	0.000248	0.103	CrCbGaD
Minocycline—IL1B—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000217	0.0745	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.0727	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000133	0.0456	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000133	0.0456	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.0445	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.0445	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.0243	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.0243	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.0238	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.0238	CbGdCrCtD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	6.75e-05	0.000648	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	6.74e-05	0.000647	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	6.66e-05	0.00064	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	6.65e-05	0.000638	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.62e-05	0.000636	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	6.6e-05	0.000634	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.57e-05	0.000631	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	6.56e-05	0.00063	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	6.52e-05	0.000626	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.47e-05	0.000621	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.45e-05	0.000619	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	6.44e-05	0.000618	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	6.41e-05	0.000615	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.4e-05	0.000614	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	6.37e-05	0.000612	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.33e-05	0.000608	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	6.22e-05	0.000597	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	6.21e-05	0.000596	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	6.2e-05	0.000596	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CRP—chronic obstructive pulmonary disease	6.16e-05	0.000592	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	6.11e-05	0.000586	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.1e-05	0.000586	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.05e-05	0.00058	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	6.04e-05	0.00058	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—chronic obstructive pulmonary disease	6.02e-05	0.000578	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	6.01e-05	0.000577	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.91e-05	0.000568	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	5.91e-05	0.000567	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—chronic obstructive pulmonary disease	5.89e-05	0.000565	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—chronic obstructive pulmonary disease	5.87e-05	0.000564	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	5.83e-05	0.00056	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.79e-05	0.000556	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	5.79e-05	0.000555	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.75e-05	0.000552	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.75e-05	0.000552	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.7e-05	0.000547	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.63e-05	0.000541	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.63e-05	0.00054	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.6e-05	0.000538	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	5.58e-05	0.000536	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR2—chronic obstructive pulmonary disease	5.57e-05	0.000535	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	5.54e-05	0.000532	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.54e-05	0.000531	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	5.53e-05	0.000531	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—chronic obstructive pulmonary disease	5.51e-05	0.000529	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	5.5e-05	0.000528	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.49e-05	0.000527	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5.47e-05	0.000525	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	5.44e-05	0.000523	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.44e-05	0.000523	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	5.43e-05	0.000521	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	5.38e-05	0.000516	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.34e-05	0.000513	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	5.27e-05	0.000506	CbGpPWpGaD
Minocycline—CASP1—Immune System—KL—chronic obstructive pulmonary disease	5.24e-05	0.000503	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	5.21e-05	0.0005	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	5.17e-05	0.000496	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.14e-05	0.000494	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.1e-05	0.00049	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	5.1e-05	0.000489	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	5.01e-05	0.000481	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	5.01e-05	0.000481	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GC—chronic obstructive pulmonary disease	5e-05	0.00048	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	5e-05	0.00048	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5e-05	0.00048	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.98e-05	0.000479	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.96e-05	0.000477	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.96e-05	0.000477	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	4.91e-05	0.000472	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.9e-05	0.00047	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—chronic obstructive pulmonary disease	4.86e-05	0.000467	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	4.76e-05	0.000457	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.75e-05	0.000456	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	4.68e-05	0.000449	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	4.68e-05	0.000449	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.67e-05	0.000448	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.65e-05	0.000447	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	4.57e-05	0.000439	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	4.56e-05	0.000438	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.56e-05	0.000437	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.47e-05	0.000429	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.43e-05	0.000426	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.43e-05	0.000425	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	4.39e-05	0.000422	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GCLC—chronic obstructive pulmonary disease	4.38e-05	0.000421	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	4.34e-05	0.000416	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.27e-05	0.00041	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.24e-05	0.000407	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	4.24e-05	0.000407	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	4.24e-05	0.000407	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—chronic obstructive pulmonary disease	4.22e-05	0.000405	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	4.2e-05	0.000403	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	4.13e-05	0.000396	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.11e-05	0.000395	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.03e-05	0.000387	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000387	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	4.01e-05	0.000385	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.01e-05	0.000385	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CTGF—chronic obstructive pulmonary disease	4e-05	0.000384	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.97e-05	0.000381	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	3.93e-05	0.000378	CbGpPWpGaD
Minocycline—CASP1—Immune System—ERBB3—chronic obstructive pulmonary disease	3.93e-05	0.000377	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.91e-05	0.000375	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.89e-05	0.000373	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	3.86e-05	0.00037	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	3.84e-05	0.000369	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.000356	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.000354	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	3.61e-05	0.000346	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	3.6e-05	0.000346	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.6e-05	0.000346	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—chronic obstructive pulmonary disease	3.59e-05	0.000345	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.56e-05	0.000342	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.55e-05	0.00034	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR2—chronic obstructive pulmonary disease	3.48e-05	0.000334	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—chronic obstructive pulmonary disease	3.44e-05	0.00033	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.44e-05	0.00033	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	3.4e-05	0.000327	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.000326	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.36e-05	0.000322	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	3.33e-05	0.00032	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.31e-05	0.000317	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.27e-05	0.000314	CbGpPWpGaD
Minocycline—IL1B—Immune System—KL—chronic obstructive pulmonary disease	3.27e-05	0.000314	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	3.12e-05	0.000299	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.07e-05	0.000295	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.05e-05	0.000292	CbGpPWpGaD
Minocycline—CYCS—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.03e-05	0.000291	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.03e-05	0.00029	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.01e-05	0.000289	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.99e-05	0.000287	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—chronic obstructive pulmonary disease	2.96e-05	0.000285	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.96e-05	0.000284	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.95e-05	0.000283	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.93e-05	0.000281	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.88e-05	0.000277	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.84e-05	0.000273	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.83e-05	0.000271	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000271	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.81e-05	0.00027	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.73e-05	0.000262	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.73e-05	0.000262	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.7e-05	0.000259	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.68e-05	0.000257	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.000257	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	2.68e-05	0.000257	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.67e-05	0.000256	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—chronic obstructive pulmonary disease	2.64e-05	0.000253	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.6e-05	0.000249	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.57e-05	0.000247	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.56e-05	0.000246	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.53e-05	0.000242	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000242	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.52e-05	0.000241	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	2.51e-05	0.000241	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.48e-05	0.000238	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.48e-05	0.000238	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.47e-05	0.000237	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB3—chronic obstructive pulmonary disease	2.45e-05	0.000236	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.39e-05	0.00023	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.39e-05	0.000229	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.34e-05	0.000224	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.27e-05	0.000218	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.25e-05	0.000216	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—chronic obstructive pulmonary disease	2.24e-05	0.000215	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—chronic obstructive pulmonary disease	2.24e-05	0.000215	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000214	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.19e-05	0.00021	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—chronic obstructive pulmonary disease	2.18e-05	0.00021	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.16e-05	0.000207	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—chronic obstructive pulmonary disease	2.15e-05	0.000207	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.14e-05	0.000205	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.09e-05	0.000201	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.07e-05	0.000199	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.02e-05	0.000194	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.93e-05	0.000186	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.93e-05	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	1.91e-05	0.000184	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.89e-05	0.000182	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.87e-05	0.000179	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000176	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—chronic obstructive pulmonary disease	1.82e-05	0.000175	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.77e-05	0.00017	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.75e-05	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000168	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.75e-05	0.000168	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—chronic obstructive pulmonary disease	1.74e-05	0.000167	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.74e-05	0.000167	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—chronic obstructive pulmonary disease	1.71e-05	0.000164	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.71e-05	0.000164	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—chronic obstructive pulmonary disease	1.71e-05	0.000164	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.69e-05	0.000162	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000158	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.62e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.62e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.59e-05	0.000153	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.57e-05	0.000151	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.54e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.52e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.51e-05	0.000145	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.5e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—chronic obstructive pulmonary disease	1.49e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.41e-05	0.000135	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.41e-05	0.000135	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.38e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.38e-05	0.000133	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000129	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.31e-05	0.000126	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—chronic obstructive pulmonary disease	1.31e-05	0.000126	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.3e-05	0.000125	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000123	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.23e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.22e-05	0.000117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.22e-05	0.000117	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.17e-05	0.000113	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.16e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—chronic obstructive pulmonary disease	1.14e-05	0.000109	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.09e-05	0.000105	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—chronic obstructive pulmonary disease	1.07e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.06e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.06e-05	0.000101	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.02e-05	9.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.45e-06	9.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.43e-06	9.05e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.54e-06	8.2e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.46e-06	8.13e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—chronic obstructive pulmonary disease	8.2e-06	7.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.16e-06	7.83e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.77e-06	7.46e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.62e-06	7.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.42e-06	7.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.23e-06	6.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.08e-06	6.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.4e-06	6.14e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.28e-06	6.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.88e-06	5.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.85e-06	5.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.68e-06	5.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.39e-06	5.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.29e-06	5.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.68e-06	4.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.59e-06	4.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.44e-06	4.26e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.06e-06	3.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.85e-06	3.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.53e-06	3.39e-05	CbGpPWpGaD
